The data presented was last updated Oct. 21, 2017.
Here is the amount 10 pharmaceutical organizations spent on lobbying efforts so far this year.
1. Pharmaceutical Research & Manufacturers of America ($19.8 million)
2. Amgen ($8.6 million)
3. Pfizer ($8.5 million)
4. Bayer ($7.05 million)
5. Novartis ($7.04 million)
6. Eli Lilly ($5.55 million)
7. Merck ($5.44 million)
8. Teva Pharmaceuticals ($4.71 million)
9. AbbVie ($4.38 million)
10. Sanofi ($4.19 million)
More articles on supply chain:
Survey: 61% of patient advocacy groups have favorable view of devicemakers
Baxter expects $70M revenue loss from Hurricane Maria
Survey: 61% of patient advocacy groups have favorable view of devicemakers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
